Table 2 Characteristics of participants in the AA and AB groups
Total (n = 30) | AA group (n = 15) | AB group (n = 15) | p-value | |
|---|---|---|---|---|
Age, years | 75.5 [72.0-82.3] | 76.0 [72.5-81.0] | 75.0 [71.5-84.0] | 0.884 |
Sex, male | 25 (83) | 13 (87) | 12 (80) | |
Body composition | ||||
Body weight, kg | 53.4 [46.8-57.2] | 54.5 [50-58.1] | 49.0 [43.5-56.8] | 0.305 |
BMI, kg/m2 | 20.5 [19.0-21.7] | 20.6 [19.0-22.7] | 19.7 [18.9-21.6] | 0.561 |
FMI, kg/m2 | 5.2 [4.6-6.7] | 5.2 [4.6-6.3] | 5.9 [4.3-7.0] | 0.740 |
FFMI, kg/m2 | 14.7 [13.2-15.6] | 15.4 [14.3-16.0] | 14.5 [13.0-15.5] | 0.300 |
Nutritional features | ||||
Albumin, g/dL | 4.0 [3.6-4.1] | 4.0 [3.7-4.2] | 4.0 [3.7-4.1] | 0.917 |
GNRI | 96.8 [91.2-102.5] | 97.1 [91.3-103.0] | 96.7 [90.8-100.0] | 0.648 |
CONUT | 2 [1-2] | 2 [1-3] | 1 [1-2] | 0.166 |
Dietary intake, kcal | 1625 [1494-1835] | 1800 [1624-1840] | 1533 [1366-1715] | 0.101 |
Energy expenditure, kcal | 1782 [1609-1901] | 1820 [1740-1929] | 1665 [1509-1821] | 0.056 |
Physical function | ||||
6MWD, m | 318 [286-349] | 323 [304-344] | 309 [255-355] | 0.590 |
QMS, kgf | 24 [20-31] | 26 [22-32] | 21 [15-29] | 0.067 |
Pulmonary function | ||||
FEV1, L | 1.15 [0.84-1.69] | 1.20 [0.90-1.65] | 1.10 [0.81-1.68] | 0.981 |
FEV1, % predicted | 53.5 [36.5-75.2] | 57.4 [35.4-74.2] | 53.5 [38.4-77.4] | 0.751 |
FEV1/FVC, % | 53.1 [42.2-68.2] | 54.0 [45.7-63.5] | 52.1 [41.6-76.1] | 1.000 |
Dyspnea, anxiety, depression and HRQOL | ||||
mMRC, 0/1/2/3/4 | 0/6/11/8/5 | 0/3/6/4/2 | 0/3/5/4/3 | 0.364 |
HADS anxiety | 7 [4-8] | 7 [4-7] | 6 [4-10] | 0.530 |
HADS depression | 7 [5-10] | 7 [6-10] | 9 [5-11] | 0.617 |
CAT | 17 [13-20] | 17 [15-22] | 15 [13-18] | 0.360 |
Blood test | ||||
CRP, mg/dL | 0.11 [0.05-0.30] | 0.20 [0.09-0.30] | 0.07 [0.04-0.23] | 0.229 |
Computed tomography | ||||
LAA, % | 28.9 [16.9-42.7] | 28.3 [13.3-43.6] | 29.50 [17.1-40.1] | 1.000 |